313 related articles for article (PubMed ID: 24897928)
41. Association of CD4 T cell count and optimal timing of antiretroviral therapy initiation with immune reconstitution inflammatory syndrome and all-cause mortality for HIV-infected adults with newly diagnosed pulmonary tuberculosis: a systematic review and meta-analysis.
Li L; Li J; Chai C; Liu T; Li P; Qu M; Zhao H
Int J Clin Exp Pathol; 2021; 14(6):670-679. PubMed ID: 34239668
[TBL] [Abstract][Full Text] [Related]
42. Disseminated infections due to Immune Reconstitution Inflammatory Syndrome after highly active antiretroviral therapy--report of 3 cases from Nigeria.
Ogoina D; Adekunle V; Obiako R; Umar A; Akolawole M; Ovosi J
Pan Afr Med J; 2011; 9():38. PubMed ID: 22355437
[TBL] [Abstract][Full Text] [Related]
43. Outcomes in HIV-infected adults with tuberculosis at clinics with and without co-located HIV clinics in Botswana.
Schwartz AB; Tamuhla N; Steenhoff AP; Nkakana K; Letlhogile R; Chadborn TR; Kestler M; Zetola NM; Ravimohan S; Bisson GP
Int J Tuberc Lung Dis; 2013 Oct; 17(10):1298-303. PubMed ID: 24025381
[TBL] [Abstract][Full Text] [Related]
44. Opportunistic diseases diminish the clinical benefit of immediate antiretroviral therapy in HIV-tuberculosis co-infected adults with low CD4+ cell counts.
Worodria W; Ssempijja V; Hanrahan C; Ssegonja R; Muhofwa A; Mazapkwe D; Mayanja-Kizza H; Reynolds SJ; Colebunders R; Manabe YC
AIDS; 2018 Sep; 32(15):2141-2149. PubMed ID: 30005014
[TBL] [Abstract][Full Text] [Related]
45. Matrix Metalloproteinases in Tuberculosis-Immune Reconstitution Inflammatory Syndrome and Impaired Lung Function Among Advanced HIV/TB Co-infected Patients Initiating Antiretroviral Therapy.
Ravimohan S; Tamuhla N; Kung SJ; Nfanyana K; Steenhoff AP; Gross R; Weissman D; Bisson GP
EBioMedicine; 2016 Jan; 3():100-107. PubMed ID: 27014741
[TBL] [Abstract][Full Text] [Related]
46. The effect of complete integration of HIV and TB services on time to initiation of antiretroviral therapy: a before-after study.
Kerschberger B; Hilderbrand K; Boulle AM; Coetzee D; Goemaere E; De Azevedo V; Van Cutsem G
PLoS One; 2012; 7(10):e46988. PubMed ID: 23071690
[TBL] [Abstract][Full Text] [Related]
47. Association of highly active antiretroviral treatment with incident tuberculosis in people living with HIV/AIDS.
Yen YF; Jen IA; Chuang PH; Chen M; Lan YC; Lee CY; Arthur Chen YM
Ann Epidemiol; 2018 Dec; 28(12):886-892.e3. PubMed ID: 29656849
[TBL] [Abstract][Full Text] [Related]
48. TB-HIV co-infection: a catastrophic comradeship.
Narendran G; Swaminathan S
Oral Dis; 2016 Apr; 22 Suppl 1():46-52. PubMed ID: 27109272
[TBL] [Abstract][Full Text] [Related]
49. Liver enzyme abnormalities and associated risk factors in HIV patients on efavirenz-based HAART with or without tuberculosis co-infection in Tanzania.
Mugusi S; Ngaimisi E; Janabi M; Minzi O; Bakari M; Riedel KD; Burhenne J; Lindquist L; Mugusi F; Sandstrom E; Aklillu E
PLoS One; 2012; 7(7):e40180. PubMed ID: 22808112
[TBL] [Abstract][Full Text] [Related]
50. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.
; Sterne JA; May M; Costagliola D; de Wolf F; Phillips AN; Harris R; Funk MJ; Geskus RB; Gill J; Dabis F; Miró JM; Justice AC; Ledergerber B; Fätkenheuer G; Hogg RS; Monforte AD; Saag M; Smith C; Staszewski S; Egger M; Cole SR
Lancet; 2009 Apr; 373(9672):1352-63. PubMed ID: 19361855
[TBL] [Abstract][Full Text] [Related]
51. Changing clinical presentation and survival in HIV-associated tuberculosis after highly active antiretroviral therapy.
Girardi E; Palmieri F; Cingolani A; Ammassari A; Petrosillo N; Gillini L; Zinzi D; De Luca A; Antinori A; Ippolito G
J Acquir Immune Defic Syndr; 2001 Apr; 26(4):326-31. PubMed ID: 11317073
[TBL] [Abstract][Full Text] [Related]
52. Immune reconstitution inflammatory syndrome in human immunodeficiency virus-infected children in Peru.
Wang ME; Castillo ME; Montano SM; Zunt JR
Pediatr Infect Dis J; 2009 Oct; 28(10):900-3. PubMed ID: 19687769
[TBL] [Abstract][Full Text] [Related]
53. Prevalent tuberculosis at HIV diagnosis in Rio de Janeiro, Brazil: the TB/HIV in Rio (THRio) Cohort.
Saraceni V; Cohn S; Cavalcante SC; Pacheco AG; Moulton LH; Chaisson RE; Durovni B; Golub JE
J Acquir Immune Defic Syndr; 2014 Sep; 67(1):98-101. PubMed ID: 24933097
[TBL] [Abstract][Full Text] [Related]
54. Early Initiation of ARV Therapy Among TB-HIV Patients in Indonesia Prolongs Survival Rates!
Maemun S; Mariana N; Rusli A; Mahkota R; Purnama TB
J Epidemiol Glob Health; 2020 Jun; 10(2):164-167. PubMed ID: 32538033
[TBL] [Abstract][Full Text] [Related]
55. Antiretroviral therapy improves survival among TB-HIV co-infected patients who have CD4+ T-cell count above 350cells/mm
Mutembo S; Mutanga JN; Musokotwane K; Alisheke L; Whalen CC
BMC Infect Dis; 2016 Oct; 16(1):572. PubMed ID: 27751168
[TBL] [Abstract][Full Text] [Related]
56. Severe manifestations of extrapulmonary tuberculosis in HIV-infected children initiating antiretroviral therapy before 2 years of age.
Walters E; Duvenhage J; Draper HR; Hesseling AC; Van Wyk SS; Cotton MF; Rabie H
Arch Dis Child; 2014 Nov; 99(11):998-1003. PubMed ID: 24938535
[TBL] [Abstract][Full Text] [Related]
57. [Treatment outcome, survival and their risk factors among new tuberculosis patients co-infected with HIV during the Ebola outbreak in Conakry].
Camara A; Sow MS; Touré A; Diallo OH; Kaba I; Bah B; Diallo TH; Diallo MS; Guilavogui T; Sow OY
Rev Epidemiol Sante Publique; 2017 Nov; 65(6):419-426. PubMed ID: 29066256
[TBL] [Abstract][Full Text] [Related]
58. Effect of highly active antiretroviral treatment on TB incidence among HIV infected children and their clinical profile, retrospective cohort study, South West Ethiopia.
Tiruneh F; Deyas Y
Sci Rep; 2020 Dec; 10(1):21468. PubMed ID: 33293656
[TBL] [Abstract][Full Text] [Related]
59. Tuberculosis risk before and after highly active antiretroviral therapy initiation: does HAART increase the short-term TB risk in a low incidence TB setting?
Pettit AC; Jenkins CA; Stinnette SE; Rebeiro PF; Blackwell RB; Raffanti SP; Shepherd BE; Sterling TR
J Acquir Immune Defic Syndr; 2011 Aug; 57(4):305-10. PubMed ID: 21423024
[TBL] [Abstract][Full Text] [Related]
60. Treatment outcomes of patients co-infected with tuberculosis and HIV at Chiang Mai University Hospital, Thailand.
Limmahakhun S; Chaiwarith R; Nuntachit N; Sirisanthana T; Supparatpinyo K
Int J STD AIDS; 2012 Jun; 23(6):414-8. PubMed ID: 22807535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
